ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
What is Driving the Growth of the Neurological Disorder Diagnostics Market?The global neurological disorder diagnostics market is experiencing significant growth, driven by the increasing prevalence ...